US Patent Issued to Roche Diagnostics Operations on Feb. 24 for "Biotin-specific monoclonal antibody and use thereof" (German Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,573, issued on Feb. 24, was assigned to Roche Diagnostics Operations Inc. (Indianapolis).

"Biotin-specific monoclonal antibody and use thereof" was invented by Michael Gerg (Munich), Lars Hillringhaus (Koenigsdorf-Schoenrain, Germany), Klaus Hirzel (Baierbrunn, Germany), Caroline Dorothea Hojer (Munich), Hans-Peter Josel (Weilheim, Germany), Christoph Seidel (Weilheim, Germany), Michael Schraeml (Penzberg, Germany) and Leopold Von Proff (Hohenpeissenberg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a monoclonal antibody capable of binding to biotin. In one embodiment the monoclonal antibody according to th...